Moreover, here we show that even TIMP3, alpha2-antiplasmin and cystatin rather than decreasing, increase in cancer patient serum compared to healthy donors and some of them in metastatic patients compared to “in situ” tumor patients. The gene discussed is CST4; the disease is cancer.